Drugdiscovery >> Pharmaceutical Companies >> News
1507
Views
Neumedicines ha a new Phase I study - drugdiscovery.com
Neumedicines ha a new Phase I study - drugdiscovery.com


Neumedicines announced that their proposal to conduct a Phase I clinical study of recombinant human interleukin-12 (rHuIL-12) for the treatment of traumatic wounds has been recommended for funding subject to negotiations by the Department of Defense (DOD) office of the Congressionally Directed Medical Research Programs (CDMRP).
Read More >>


Tags: Neumedicines, phase I study, phase I clinical trial, drugresearch, drug discovery - May 1, 2014
Related Articles
2215
Views
Novartis has announced the results of phase 4 INSTEAD study Novartis has announced the results of phase 4 INSTEAD study
Novartis has announced the result of a Phase 4 INSTEAD research made to imporve its new COPD drug. Once-daily indacaterol has shown very promising data. Read More >>

Tags: durg development, INSTEAD Swift study, GSK, Novartis, pharmaceutical news, pharmaceutical companies

4092
Views
A new leukemia drug id going to be made by Pfizer A new leukemia drug id going to be made by Pfizer
Avalliaon Group and Pfizer work together on developing a new type of pharma. The leukemia drug is in Phase 3 clinical trial now. Read More >>

Tags: Phase , clinical trial, pharma

5413
Views
Isis shares climbe after positive results from its spinal muscular atrophy drug study Isis shares climbe after positive results from its spinal muscular atrophy drug study
Isis Pharmaceuticals drug designed to treat spinal muscular atrophy showed success in a mid- stage study. This announcement led to a raise of company’s shares. Read More >>

Tags: news, Isis Pharmaceutical, spinal muscular atrophy, clinical trial, shares, experimental drug

1650
Views
Pharmaceutical companies team up to deal with Pharmaceutical companies team up to deal with "big data challenge"
Cancer Research UK says it teams up with other oharmaceutical and technical companies to solve the big data problems. huge amounts of DATA received from studies is going to be analyzed now. Read More >>

Tags: DATA, analisys, study, big data, cancer research, big data cancer research, Cancer research UK

3164
Views
Parkinson's collaboration of Roche and Prothena Parkinson's collaboration of Roche and Prothena
Roche and Prothena formed a great collaboration. Their new project is going to be in Phase I clinical trial next year. Read More >>

Tags: phase I, Roche Prothena

4700
Views
Agenus shares fall after GSK’s MAGE-A3 failure in a Phase 3 trial Agenus shares fall after GSK’s MAGE-A3 failure in a Phase 3 trial
Glaxo’s MAGE-A3 immunotherapy treatment includes Agenus' SQ-21 Stimulon vaccine adjuvant which is designed to make drugs more effective. GSK reported that MAGE-A3 failed to meet its first goal in a Read More >>

Tags: Agenus, shares, GSK, melanoma clinical trial, MAGE-A3, SQ-21 Stimulon vaccine adjuvant, vaccine adjuvant

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013